» Articles » PMID: 36002092

T-helper 2 Mechanisms Involved in Human Rhinovirus Infections and Asthma

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Human rhinovirus (HRV) is the most common causative agent for the common cold and its respiratory symptoms. For those with asthma, cystic fibrosis, or chronic obstructive pulmonary disease, HRVs can lead to severe and, at times, fatal complications. Furthermore, an array of innate and adaptive host immune responses leads to varying outcomes ranging from subclinical to severe. In this review, we discuss the viral pathogenesis and host immune responses associated with this virus. Specifically, we focus on the immune responses that might skew a T-helper type 2 response, including alarmins, in those with allergic asthma. We also discuss the role of a poor innate immune response with interferons. Finally, we consider therapeutic options for HRV-associated exacerbations of asthma, including biologics and intranasal sprays on the basis of the current literature.

Citing Articles

Advances in the Relationship between Respiratory Viruses and Asthma.

Romero-Tapia S, Guzman Priego C, Del-Rio-Navarro B, Sanchez-Solis M J Clin Med. 2023; 12(17).

PMID: 37685567 PMC: 10488270. DOI: 10.3390/jcm12175501.


EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination.

Krug P, Wang L, Shi W, Kong W, Moss D, Yang E Sci Adv. 2023; 9(20):eadg6076.

PMID: 37196074 PMC: 10191429. DOI: 10.1126/sciadv.adg6076.


Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease.

Shute J Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111341 PMC: 10141002. DOI: 10.3390/ph16040584.

References
1.
Wang Y, Angkasekwinai P, Lu N, Voo K, Arima K, Hanabuchi S . IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med. 2007; 204(8):1837-47. PMC: 2118667. DOI: 10.1084/jem.20070406. View

2.
Caliskan M, Bochkov Y, Kreiner-Moller E, Bonnelykke K, Stein M, Du G . Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med. 2013; 368(15):1398-407. PMC: 3755952. DOI: 10.1056/NEJMoa1211592. View

3.
Barnes P . Targeting cytokines to treat asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2018; 18(7):454-466. DOI: 10.1038/s41577-018-0006-6. View

4.
Teach S, Gill M, Togias A, Sorkness C, Arbes Jr S, Calatroni A . Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015; 136(6):1476-1485. PMC: 4679705. DOI: 10.1016/j.jaci.2015.09.008. View

5.
Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View